Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | XmAb18968 |
Trade Name | |
Synonyms | XmAb-18968|XmAb 18968 |
Drug Descriptions |
XmAb18968 is a bispecific T-cell engager that targets both CD38 and CD3, potentially leading to a cytotoxic T-lymphocyte mediated response against tumor cells expressing CD38 (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 2515; NCI Drug Dictionary). |
DrugClasses | CD3 Antibody 103 CD38 Antibody 20 |
CAS Registry Number | NA |
NCIT ID | C184369 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
XmAb18968 | XmAb18968 | 0 | 1 |